Literature DB >> 9829104

Tear break-up time: clinical procedures and their effects.

P Cho1, L Leung, A Lam, A Choi.   

Abstract

Three successive (representative) values of fluorescein-instillation TBUT (tear break-up time) were obtained from a group of young Hong Kong (HK)-Chinese. The median TBUT1, TBUT2 and TBUT3 were 3.2, 3.8 and 4.5 sec, respectively. Wilcoxon signed-rank tests showed that TBUT1 was significantly different from TBUT2 and TBUT3, but there was no difference between TBUT2 and TBUT3. It is therefore important, when measuring the TBUT, to specify which TBUT value was taken as the representative TBUT. Fluorescein was reapplied about six min after the first application, and the TBUT value re-determined (TBUTR). The median TBUTR was not significantly different from TBUT1. The subjects were requested to return another day and TBUT values (TBUTW) were determined, with the subjects opening their eyes as wide as possible, such that the palpebral aperture size was increased. The mean +/- SD normal palpebral aperture size was 10.0 +/- 1.3 mm, and the mean +/- SD palpebral aperture size with the eyes wide open was 11.4 +/- 1.5 mm. The median TBUTW (3.6 sec) was significantly longer than the median TBUT1 (3.0 sec), but this difference appeared to be due to the extremely long TBUTW of one subject; no significant difference was found between the median TBUTW (3.4 sec) and TBUT1 (2.8 sec) when data from this subject were excluded. There was no significant correlation between changes in palpebral size and TBUT value.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9829104

Source DB:  PubMed          Journal:  Ophthalmic Physiol Opt        ISSN: 0275-5408            Impact factor:   3.117


  5 in total

1.  Dynamic changes in the air-tear film interface modulation transfer function.

Authors:  Teresa Ferrer-Blasco; Santiago García-Lázaro; Robert Montés-Micó; Alejandro Cerviño; Jose M González-Méijome
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-09-25       Impact factor: 3.117

Review 2.  Placebo administration for dry eye disease: a level I evidence based systematic review and meta-analysis.

Authors:  Julia Prinz; Nicola Maffulli; Matthias Fuest; Peter Walter; Frank Hildebrand; Filippo Migliorini
Journal:  Int J Clin Pharm       Date:  2022-08-08

3.  Acupuncture for the management of dry eye disease.

Authors:  Julia Prinz; Nicola Maffulli; Matthias Fuest; Peter Walter; Frank Hildebrand; Filippo Migliorini
Journal:  Front Med       Date:  2022-09-24       Impact factor: 9.927

4.  Evaluation of the adhesive properties of the cornea by means of optical coherence tomography in patients with meibomian gland dysfunction and lacrimal tear deficiency.

Authors:  Pietro Emanuele Napoli; Franco Coronella; Giovanni Maria Satta; Maria Silvana Galantuomo; Maurizio Fossarello
Journal:  PLoS One       Date:  2014-12-23       Impact factor: 3.240

5.  Efficacy and Safety of Preservative-free Latanoprost Eyedrops Compared with Preserved Prostaglandin Analogues in Patients with Open-angle Glaucoma.

Authors:  Hyo Jin Seong; Kwanghyun Lee; Seung Jae Lee; Sangah Kim; Jong Woon Park
Journal:  Korean J Ophthalmol       Date:  2021-06-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.